Consistent with this research, Tang et al. (2022) identified CD161 as a tumor immunological phenotype-related gene capable of predicting prognosis as well as the effectiveness of immunotherapy in HCC. This evidence concerns the gene KLRB1 and hepatocellular carcinoma.